These data highlight for the first time a role for periostin in pulmonary hypertension and RV dysfunction and suggest that strategies which interrupt Cfib-mediated expression and secretion of periostin may be therapeutically viable in this disease. The gene discussed is POSTN; the disease is pulmonary arterial hypertension.